Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Small Molecules, Standards & Regulation

Patients Above Profits

This article was published in our sister publication, The Small Molecule Manufacturer, which celebrates the field of small molecule drug development and manufacturing with interviews and articles focusing on success stories, equipment, and new processing techniques.

Read more about The Small Molecule Manufacturer here

Civica Rx raised a few eyebrows in 2018, when it was founded as a not-for-profit to manufacture important generic medicines for the US market. But, since then, the company has gone from strength to strength – 18 medicines are now in production or shipped for use in hospitals across the USA.

A recent announcement from the company draws attention to the signing of a long-term (seven-year) agreement with Thermo Fisher Scientific, which will drive the development of Civica-owned Abbreviated New Drug Applications (ANDAs). Initially, the collaboration will focus on nine critical medications that have been in short supply or where the drug supply chain is considered fragile because there are too few manufacturers making the drugs.

The company also notes its interest in talking to generic drug manufacturers who are considering retiring or withdrawing their ANDA for essential medicines that are at risk of being in short supply.

Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Stephanie Sutton

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent seven years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register